Online inquiry

IVTScrip™ mRNA-Human ARL6IP1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK23247MR)

This product GTTS-WK23247MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARL6IP1 protein. This product can be used in Gonadal mitotic phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001313858.1
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 23204
UniProt ID Q15041
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARL6IP1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK23247MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK24734MR IVTScrip™ mRNA-Human ARL13B, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARL13B
GTTS-WK27234MR IVTScrip™ mRNA-Human ASZ1, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ASZ1
GTTS-WK17333MR IVTScrip™ mRNA-Human ANKRD62, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ANKRD62
GTTS-WK19540MR IVTScrip™ mRNA-Human AJUBA, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AJUBA
GTTS-WK28654MR IVTScrip™ mRNA-Human ARMC3, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARMC3
GTTS-WK25632MR IVTScrip™ mRNA-Human ARL1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARL1
GTTS-WK12980MR IVTScrip™ mRNA-Human ABLIM3, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ABLIM3
GTTS-WK17236MR IVTScrip™ mRNA-Human alpha-Sarcoglycan, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA alpha-Sarcoglycan
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW